Transplantation models
| Experimental models . | MHC haplotype . | MHC disparity . | Donor cells . | |||
|---|---|---|---|---|---|---|
| Recipient . | Donor . | TCD BM . | T cells . | |||
| Genotype . | Subsets . | Genotype . | ||||
| [B6→BDF1] (BM/T) | ||||||
| WT/− | H-2b/d | H-2b | MHC I and II | WT | — | — |
| WT/WT | H-2b/d | H-2b | MHC I and II | WT | CD4/CD8 | WT |
| lpr/− | H-2b/d | H-2b | MHC I and II | Faslpr/lpr | — | — |
| lpr/WT | H-2b/d | H-2b | MHC I and II | Faslpr/lpr | CD4/CD8 | WT |
| WT/gld | H-2b/d | H-2b | MHC I and II | WT | CD4/CD8 | FasLgld /gld |
| [B6→bm1] | H-2bm1 | H-2b | MHC I | WT | CD8 | WT |
| [B6→bm12] | H-2bm12 | H-2b | MHC II | WT | CD4 | WT |
| [B6gld /gld →bm12] | H-2bm12 | H-2b | MHC II | WT | CD4 | FasLgld /gld |
| Experimental models . | MHC haplotype . | MHC disparity . | Donor cells . | |||
|---|---|---|---|---|---|---|
| Recipient . | Donor . | TCD BM . | T cells . | |||
| Genotype . | Subsets . | Genotype . | ||||
| [B6→BDF1] (BM/T) | ||||||
| WT/− | H-2b/d | H-2b | MHC I and II | WT | — | — |
| WT/WT | H-2b/d | H-2b | MHC I and II | WT | CD4/CD8 | WT |
| lpr/− | H-2b/d | H-2b | MHC I and II | Faslpr/lpr | — | — |
| lpr/WT | H-2b/d | H-2b | MHC I and II | Faslpr/lpr | CD4/CD8 | WT |
| WT/gld | H-2b/d | H-2b | MHC I and II | WT | CD4/CD8 | FasLgld /gld |
| [B6→bm1] | H-2bm1 | H-2b | MHC I | WT | CD8 | WT |
| [B6→bm12] | H-2bm12 | H-2b | MHC II | WT | CD4 | WT |
| [B6gld /gld →bm12] | H-2bm12 | H-2b | MHC II | WT | CD4 | FasLgld /gld |
Congenic markers of each donor-recipient pair is otherwise indicated. lpr and gld are loss-of-function mutation of Fas and FasL, respectively. Groups are labeled as source of BM/source of splenic T cells (BM/T).